文献速递血栓与止血

构象依赖性阻断活化VWF可改善小鼠创伤性脑损伤结局

Conformation-dependent blockage of activated VWF improves outcomes of traumatic brain injury in mice.
PubMed 文献 · Blood · 2021-01-01

研究验证急性创伤性脑损伤(TBI)释放的血管性血友病因子(VWF)因A1结构域暴露而呈高黏附性,导致TBI诱导的血管渗漏和消耗性凝血病。用VWF A2结构域蛋白选择性阻断该高黏附VWF,可使重度TBI雄性C57BL/6J小鼠死亡减少>50%并显著改善神经功能,且出血风险极小。

要点

  • 急性TBI释放的VWF因A1结构域暴露而呈高黏附性,是TBI-IC的因果因素。
  • A2蛋白通过腹腔注射或静脉输注阻断A1结构域,使TBI小鼠死亡减少>50%。
  • A2蛋白保护内皮免受细胞外囊泡损伤,减少血小板活化及微囊泡化,预防高凝状态。

核心结论

  • VWF在TBI-IC发生中起因果作用,是这一危及生命并发症的治疗靶点。
  • 选择性阻断高黏附VWF的A1结构域可预防TBI-IC并改善神经功能,出血风险极小。

研究设计与样本

  • 研究采用重度侧方液体冲击损伤的雄性C57BL/6J小鼠模型。
  • A2蛋白通过腹腔注射或静脉输注给药。

主要发现

  • A2使TBI诱导的死亡减少>50%,并显著改善神经功能。
  • A2保护内皮免受细胞外囊泡诱导的损伤,减少TBI诱导的血小板活化和微囊泡化。
  • A2预防TBI诱导的高凝状态。

临床怎么用

  • A2蛋白通过腹腔注射或静脉输注给药,可选择性阻断急性TBI释放的高黏附VWF的A1结构域。
  • 该策略在减少死亡和改善神经功能的同时出血风险极小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Traumatic brain injury-induced coagulopathy (TBI-IC) causes life-threatening secondary intracranial bleeding. Its pathogenesis differs mechanistically from that of coagulopathy arising from extracranial injuries and hemorrhagic shock, but it remains poorly understood. We report results of a study designed to test the hypothesis that von Willebrand factor (VWF) released during acute TBI is intrinsically hyperadhesive because its platelet-binding A1-domain is exposed and contributes to TBI-induced vascular leakage and consumptive coagulopathy. This hyperadhesive VWF can be selectively blocked by a VWF A2-domain protein to prevent TBI-IC and to improve neurological function with a minimal risk of bleeding. We demonstrated that A2 given through intraperitoneal injection or IV infusion reduced TBI-induced death by >50% and significantly improved the neurological function of C57BL/6J male mice subjected to severe lateral fluid percussion injury. A2 protected the endothelium from extracellular vesicle-induced injury, reducing TBI-induced platelet activation and microvesiculation, and preventing a TBI-induced hypercoagulable state. A2 achieved this therapeutic efficacy by specifically blocking the A1 domain exposed on the hyperadhesive VWF released during acute TBI. These results suggest that VWF plays a causal role in the development of TBI-IC and is a therapeutic target for this life-threatening complication of TBI.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Xu X, Wang C, Wu Y, et al. Conformation-dependent blockage of activated VWF improves outcomes of traumatic brain injury in mice. Blood. 2021. PMID: 33507292. doi:10.1182/blood.2020007364

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。